Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JAMES BRADLEY MACDONALD

Allopathic & Osteopathic Physicians Dermatology

NPI
1750517736
CMS profile
527333
Location
LEHI, UT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$1,767.25

104 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,668.25 103
Education $99.00 1

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JAMES BRADLEY MACDONALD

NPI 1750517736 · CMS profile ID 527333

Allopathic & Osteopathic Physicians / Dermatology

LEHI, UT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1750517736?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JAMES BRADLEY MACDONALD, NPI 1750517736, CMS profile ID 527333. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1750517736?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). JAMES BRADLEY MACDONALD, NPI 1750517736, CMS profile ID 527333. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1750517736?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
JAMES BRADLEY MACDONALD, NPI 1750517736, CMS profile ID 527333, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1750517736?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

104 matching records · $1,767.25 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 104 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 104.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
SUN PHARMACEUTICAL INDUSTRIES INC. $5.3307/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152156132 CMS
ABBVIE INC. $22.8507/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104918546 CMS
ABBVIE INC. $0.7307/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104918548 CMS
Amgen Inc. $19.0807/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117315866 CMS
Regeneron Healthcare Solutions, Inc. $17.0307/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114105099 CMS
Janssen Biotech, Inc. $22.1507/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078783155 CMS
GENZYME CORPORATION $24.0506/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139868446 CMS
ABBVIE INC. $15.4806/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104918544 CMS
Arcutis Biotherapeutics, Inc. $17.8506/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1121051353 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $15.6206/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152156130 CMS
PFIZER INC. $13.0906/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131618169 CMS
Dermavant Sciences, Inc. $13.5705/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1127901504 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $24.9405/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152156128 CMS
ABBVIE INC. $16.9905/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104918542 CMS
ABBVIE INC. $25.7605/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104918540 CMS
ABBVIE INC. $1.0705/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104918536 CMS
ABBVIE INC. $2.6905/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104918538 CMS
Amgen Inc. $15.3405/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117315862 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $5.5905/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152156126 CMS
Janssen Biotech, Inc. $23.8505/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078783226 CMS
UCB, Inc. $12.3605/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143339137 CMS
LEO Pharma Inc. $23.8905/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152641155 CMS
ABBVIE INC. $3.1005/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104918532 CMS
ABBVIE INC. $4.3805/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104918534 CMS
Arcutis Biotherapeutics, Inc. $18.7604/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1121051355 CMS
ABBVIE INC. $16.1104/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104918530 CMS
Amgen Inc. $16.0804/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117315864 CMS
Incyte Corporation $23.3004/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141241702 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.2304/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118139584 CMS
UCB, Inc. $2.6804/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143339128 CMS
UCB, Inc. $24.7704/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143339133 CMS
ABBVIE INC. $15.6303/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104918528 CMS
UCB, Inc. $11.2203/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143339124 CMS
Janssen Biotech, Inc. $99.0003/21/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078783175 CMS
Lilly USA, LLC $19.3203/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135019734 CMS
Janssen Biotech, Inc. $21.5703/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078783117 CMS
Regeneron Healthcare Solutions, Inc. $23.9203/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114105097 CMS
Novartis Pharmaceuticals Corporation $19.0403/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087024050 CMS
Amgen Inc. $15.1003/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117315860 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $22.1803/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152156124 CMS
LEO Pharma Inc. $20.2403/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152641153 CMS
Lilly USA, LLC $19.3702/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135019736 CMS
Janssen Biotech, Inc. $16.4102/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078783143 CMS
ABBVIE INC. $20.9002/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104918526 CMS
Galderma Laboratories, L.P. $15.1602/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145314167 CMS
Janssen Biotech, Inc. $19.8102/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078783203 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $18.2002/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152156122 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $21.3601/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152156120 CMS
Janssen Biotech, Inc. $21.3501/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078783223 CMS
Janssen Biotech, Inc. $3.2201/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078783179 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,349.40 94
PY2020 $1,205.88 64
PY2021 $1,288.78 77
PY2022 $1,348.04 75
PY2023 $1,131.03 68
PY2024 $1,767.25 104
PY2025 $6,186.39 125

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $24,655.05 13
PY2023 Principal investigator $4,636.90 6
PY2022 Principal investigator $24,914.80 6
PY2021 Principal investigator $39,881.95 11
PY2020 Principal investigator $135,188.32 25
PY2019 Principal investigator $70,936.90 14

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

13 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 2 Arcutis Biotherapeutics, Inc. $1,495.00 12/02/2024 Non-covered Recipient Entity
Elligo Health Research, Inc.
A Phase 3, Multicenter, Open-Label Extension Study of the Long-Term Safety of ARQ-151 Cream 0.15% and ARQ-151 Cream 0.05% in Subjects with Atopic Dermatitis No dispute reported 06/30/2026 1121031364
Principal investigator 1 ABBVIE INC. $1,605.90 10/03/2024 Non-covered Recipient Entity
ASPEN CLINICAL RESEARCH LLC
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2) No dispute reported 06/30/2026 1100747514
Principal investigator 1 ABBVIE INC. $2,048.25 09/03/2024 Non-covered Recipient Entity
ASPEN CLINICAL RESEARCH LLC
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2) No dispute reported 06/30/2026 1100739790
Principal investigator 1 ABBVIE INC. $4,718.00 08/02/2024 Non-covered Recipient Entity
ASPEN CLINICAL RESEARCH LLC
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2) No dispute reported 06/30/2026 1100734628
Principal investigator 1 Galderma Laboratories, L.P. $537.55 07/18/2024 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
A Randomized, Double-Blind, Placebo-Controlled Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab No dispute reported 06/30/2026 1156049017
Principal investigator 1 ABBVIE INC. $1,276.50 07/05/2024 Non-covered Recipient Entity
ASPEN CLINICAL RESEARCH LLC
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2) No dispute reported 06/30/2026 1100727784
Principal investigator 1 Galderma Laboratories, L.P. $2,962.45 06/13/2024 Non-covered Recipient Entity
CLINICAL TRIAL SOURCE LLC
A Randomized, Double-Blind, Placebo-Controlled Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab No dispute reported 06/30/2026 1156048817
Principal investigator 1 ABBVIE INC. $305.20 06/05/2024 Non-covered Recipient Entity
ASPEN CLINICAL RESEARCH LLC
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2) No dispute reported 06/30/2026 1100720872
Principal investigator 1 ABBVIE INC. $610.40 05/08/2024 Non-covered Recipient Entity
ASPEN CLINICAL RESEARCH LLC
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2) No dispute reported 06/30/2026 1100716568
Principal investigator 1 ABBVIE INC. $5,369.10 04/04/2024 Non-covered Recipient Entity
ASPEN CLINICAL RESEARCH LLC
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2) No dispute reported 06/30/2026 1100712316
Principal investigator 1 Arcutis Biotherapeutics, Inc. $900.00 03/18/2024 Non-covered Recipient Entity
ASPEN CLINICAL RESEARCH LLC
A Phase 3, Multicenter, Open-Label Extension Study of the Long-Term Safety of ARQ-151 Cream 0.15% and ARQ-151 Cream 0.05% in Subjects with Atopic Dermatitis No dispute reported 06/30/2026 1121031070
Principal investigator 1 ABBVIE INC. $1,220.80 03/07/2024 Non-covered Recipient Entity
ASPEN CLINICAL RESEARCH LLC
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2) No dispute reported 06/30/2026 1100706742
Principal investigator 1 ABBVIE INC. $1,605.90 01/10/2024 Non-covered Recipient Entity
ASPEN CLINICAL RESEARCH LLC
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2) No dispute reported 06/30/2026 1100699523